User profiles for Hwai-I Yang
 | Hwai-I Yang 楊懷壹, Ph.D.Genomics Research Center, Academia Sinica Verified email at gate.sinica.edu.tw Cited by 23569 |
[PDF][PDF] Hepatitis B virus DNA levels and outcomes in chronic hepatitis B
Serum hepatitis B virus (HBV) DNA levels can fluctuate markedly during the course of
chronic HBV infection. Both case‐control and cohort studies have shown a significant, dose‐…
chronic HBV infection. Both case‐control and cohort studies have shown a significant, dose‐…
Natural history of chronic hepatitis B REVEALed
Chronic hepatitis B is a worldwide public health challenge. Knowledge of natural history of
chronic hepatitis B is important for the management of the disease. A community‐based …
chronic hepatitis B is important for the management of the disease. A community‐based …
[HTML][HTML] Epidemiology and natural history of hepatitis C virus infection
Hepatitis C virus (HCV) affects 130-210 million people worldwide and is one of the major
risk factors for hepatocellular carcinoma. Globally, at least one third of hepatocellular …
risk factors for hepatocellular carcinoma. Globally, at least one third of hepatocellular …
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
ContextSerum hepatitis B virus (HBV) DNA level is a marker of viral replication and efficacy
of antiviral treatment in individuals with chronic hepatitis B.ObjectiveTo evaluate the …
of antiviral treatment in individuals with chronic hepatitis B.ObjectiveTo evaluate the …
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
Background & Aims: Cirrhosis develops as a result of hepatic inflammation and subsequent
fibrosis in chronic hepatitis B infection. We report on the relationship between hepatitis B …
fibrosis in chronic hepatitis B infection. We report on the relationship between hepatitis B …
[HTML][HTML] Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang, SN Lu, YF Liaw, SL You, CA Sun… - … England Journal of …, 2002 - Mass Medical Soc
Background The presence of hepatitis B e antigen (HBeAg) in serum indicates active viral
replication in hepatocytes. HBeAg is thus a surrogate marker for the presence of hepatitis B …
replication in hepatocytes. HBeAg is thus a surrogate marker for the presence of hepatitis B …
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
HI Yang, SH Yeh, PJ Chen, UH Iloeje… - Journal of the …, 2008 - academic.oup.com
Background The risk of hepatocellular carcinoma (HCC) increases with increasing level of
hepatitis B virus (HBV) in serum (viral load). However, it is unclear whether genetic …
hepatitis B virus (HBV) in serum (viral load). However, it is unclear whether genetic …
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Background Therapy for chronic hepatitis B reduces the risk of progressing to hepatocellular
carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This …
carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This …
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan
Background & Aims: This study investigated whether obesity, diabetes, and other metabolic
factors are independently associated with hepatocellular carcinoma (HCC), stratified by …
factors are independently associated with hepatocellular carcinoma (HCC), stratified by …
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study
Background. The study aimed to evaluate the risk of hepatitis C virus (HCV) infection on hepatic
and extrahepatic deaths. Methods. A cohort of 23 820 adults aged 30–65 years old were …
and extrahepatic deaths. Methods. A cohort of 23 820 adults aged 30–65 years old were …
